39th annual Congress of the European College of Neuropsychopharmacology — will convene leading psychiatrists, neuroscientists, neurologists, psychologists and mental‑health researchers from around the world in Munich, Germany from 10–13 October 2026. Hosted at the ICM – International Congress Center Messe München, the congress will feature plenary lectures, symposia, poster and e‑poster sessions, industry‑exhibition and networking opportunities, highlighting the latest advances in neuroscience, neuropsychiatry, brain research and CNS therapeutics. ECNP 2026 promises to be a global hub for breakthrough scientific discoveries, clinical innovation, and collaborative exchange aimed at advancing brain health and neuropsychiatric care.